tiprankstipranks
Advertisement
Advertisement

AORT Stock Latest News

Artivion upgraded to Buy from Neutral at Ladenburg
The FlyArtivion upgraded to Buy from Neutral at Ladenburg
5d ago
AORT
Artivion’s PMA for Nexus Aortic Arch System approved by the FDA
PremiumThe Fly
Artivion’s PMA for Nexus Aortic Arch System approved by the FDA
8d ago
AORT
Artivion’s New Chord-X Mitral Valve Study Sets Stage for Long-Term Value
PremiumCompany Announcements
Artivion’s New Chord-X Mitral Valve Study Sets Stage for Long-Term Value
2M ago
AORT
Artivion Earnings Call Highlights Growth, Margin Momentum
PremiumCompany Announcements
Artivion Earnings Call Highlights Growth, Margin Momentum
2M ago
AORT
Artivion price target lowered to $48 from $51 at Canaccord
PremiumThe Fly
Artivion price target lowered to $48 from $51 at Canaccord
2M ago
AORT
Artivion reports Q4 non-GAAP EPS 17c, consensus 18c
PremiumThe FlyArtivion reports Q4 non-GAAP EPS 17c, consensus 18c
2M ago
AORT
Artivion sees 2026 revenue $486M-$504M, consensus $490.19M
Premium
The Fly
Artivion sees 2026 revenue $486M-$504M, consensus $490.19M
2M ago
AORT
AORT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AORT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
AORT
Artivion: Positive Clinical Data and Pipeline Progress Support Sustained Growth and Buy Rating
PremiumRatings
Artivion: Positive Clinical Data and Pipeline Progress Support Sustained Growth and Buy Rating
2M ago
AORT
Artivion announces presentations of clinical data from Nexus and AMD trials
PremiumThe Fly
Artivion announces presentations of clinical data from Nexus and AMD trials
2M ago
AORT
Artivion: Strategic Growth, Market Expansion, and Long-Term Value Creation Drive Buy Rating
PremiumRatings
Artivion: Strategic Growth, Market Expansion, and Long-Term Value Creation Drive Buy Rating
4M ago
AORT
Artivion Inc. Reports Robust Earnings Amid Growth Challenges
PremiumCompany Announcements
Artivion Inc. Reports Robust Earnings Amid Growth Challenges
5M ago
AORT
Artivion price target raised to $55 from $46 at Stifel
PremiumThe FlyArtivion price target raised to $55 from $46 at Stifel
5M ago
AORT
Artivion price target raised to $55 from $45 at Lake Street
Premium
The Fly
Artivion price target raised to $55 from $45 at Lake Street
5M ago
AORT
Artivion price target raised to $50 from $40 at Oppenheimer
Premium
The Fly
Artivion price target raised to $50 from $40 at Oppenheimer
5M ago
AORT
Artivion price target raised to $40 from $38 at Ladenburg
PremiumThe Fly
Artivion price target raised to $40 from $38 at Ladenburg
5M ago
AORT
Artivion price target raised to $51 from $50 at Canaccord
PremiumThe Fly
Artivion price target raised to $51 from $50 at Canaccord
5M ago
AORT
Artivion price target raised to $53 from $47 at Citizens JMP
PremiumThe Fly
Artivion price target raised to $53 from $47 at Citizens JMP
5M ago
AORT
Artivion’s Strong Q3 Performance and Growth Prospects Justify Buy Rating
PremiumRatings
Artivion’s Strong Q3 Performance and Growth Prospects Justify Buy Rating
5M ago
AORT
Artivion Inc. Reports Strong Q3 2025 Financial Results
PremiumCompany AnnouncementsArtivion Inc. Reports Strong Q3 2025 Financial Results
5M ago
AORT
Artivion reports Q3 non-GAAP EPS 16c, consensus 15c
Premium
The Fly
Artivion reports Q3 non-GAAP EPS 16c, consensus 15c
5M ago
AORT
Artivion raises FY25 revenue view to $439M-$445M from $435M-$443M
Premium
The Fly
Artivion raises FY25 revenue view to $439M-$445M from $435M-$443M
5M ago
AORT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >